Semax
ACTH(4-7) analog
A synthetic ACTH-fragment analog studied mainly in Russian and regional neuroprotection literature.
Mechanism
Proposed neurotrophic and melanocortin-related signaling
Protocol studied in research
Study design shown in plain language. This is not a personal dosing recommendation.
Human evidence is absent, limited or not confirmatory
Anecdotal schedules are excluded because frequency of online repetition does not establish identity, safety, or a clinically meaningful dose.
Community-Reported Research Schedules
Descriptive community patterns are separated from clearly labeled trial-derived reference rows. Neither is personal dosing guidance.
Published intranasal and sparse subcutaneous evidence should remain separate.
| Research context or phase | Amount per administration | Schedule total | Frequency | Timing | Administration | Evidence level |
|---|---|---|---|---|---|---|
| Common intranasal range | 200–600 mcg | 200–600 mcg/day | Once or divided daily | Morning through early afternoon | Intranasal | Community-reported |
Important: Repetition in online communities does not establish product identity, safety, effectiveness, or an appropriate exposure. Route-specific schedules, half-life estimates and reported cycle lengths are shown for comparison only.
Example Reconstitution Protocol
A hypothetical concentration calculation for literacy and review—not preparation, administration, or dosing instructions.
Important: Vial strength, diluent identity, compatibility, sterility, stability and beyond-use time are product-specific. Never infer them from this arithmetic example. Use manufacturer, pharmacy, study, or licensed-clinician instructions for an actual preparation.
Cycle & Supplies Planning
Phase-by-phase cycle math showing how long a vial lasts and the estimated supplies required.
No single, consistently reported subcutaneous amount-and-frequency pair is available for a responsible automatic supply calculation.
Planning boundary: These are arithmetic examples based on the displayed research schedule—not personal dosing or purchasing instructions. Confirm product format, compatibility, route, sterility, storage, and discard timing independently. U-100 units measure liquid volume, not potency.
Safety signal
Evidence, product standards and approved status vary by country; long-term safety is not well defined.
Reported doses describe either a specific study or an unverified community pattern. Neither is personal medical guidance.